Huma’s approach to international healthcare means patients are monitored outside of hospital and given proactive medical intervention before a visit to hospital is required.
Because this makes the best use of resources, it also improves patient outcomes and reduces long-term healthcare costs for employers.
What does the partnership mean for the industry?
The five-year deal sees a €20-million investment by Atos, which will improve patient care by accelerating the integration of the Huma platform with other clinical programmes.
Dan Vahdat, CEO and Founder of Huma, said the partnership will take them to a new level. “We have already shown that we can create a service for a new disease area in a matter of weeks, as we did during the pandemic, and that we can go live with over 100 clinics in a day,” he explained.
“Atos will supercharge our work so we can offer services at scale, anywhere in the world across delivery of care and pharma collaborations leading to more people living longer, fuller lives.”
Huma provides hospitals-at-home care for patients across England, Wales, Germany and the UAE. Evidence shows that this approach can double clinical capacity, reduce readmission rates by a third and reduce costs.
It’s proving to be a hot topic in the industry - just last month we reported that Babylon’s CEO Dr Ali Parsa believed it was time to shift to proactive, not reactive healthcare at the CNBC Healthy Returns Summit.
The one-day event brought together healthcare investors, CEOS and technologists and explored innovations in the healthcare sphere that could drive positive change.